找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Update of Non-Pharmacological Therapy for Heart Failure; Koichiro Kinugawa,Teruhiko Imamura Book 2020 Springer Nature Singapore Pte Ltd. 2

[复制链接]
楼主: 恐怖
发表于 2025-3-28 15:52:27 | 显示全部楼层
Device Monitoring,eased procedural risks of invasive assessments. The HVAD flow waveform is a variable under active investigation which might also provide an estimation of filling pressures. The methodology would lead to the concept of smart pump, which can adjust device setting automatically by monitoring hemodynamics.
发表于 2025-3-28 20:40:16 | 显示全部楼层
发表于 2025-3-29 02:07:37 | 显示全部楼层
MitraClip,over the optimal medical therapy has not been fully established thus far. Nevertheless, given we often experience a significant improvement of such mitral regurgitation by using MitraClip system, optimal patient selection and management by the heart team might be a key to success.
发表于 2025-3-29 05:26:01 | 显示全部楼层
发表于 2025-3-29 08:54:57 | 显示全部楼层
发表于 2025-3-29 12:05:41 | 显示全部楼层
发表于 2025-3-29 18:33:24 | 显示全部楼层
发表于 2025-3-29 20:48:43 | 显示全部楼层
ractical guidelines on the monitoring using those devices, a.This book offers essential guidance on the diagnosis, management and treatment of heart failure using the latest Ventricular Assist Devices and approaches such as Cardiac Resynchronization Therapy, Implantable Cardioverter Defibrillator, N
发表于 2025-3-30 02:08:57 | 显示全部楼层
发表于 2025-3-30 05:09:07 | 显示全部楼层
MVP/LV Plasty, and left ventriculoplasty have been introduced for the treatment of congestive heart failure. Surgeons must refine surgical indications for determining which patients are the best candidates for each of these procedures.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 11:21
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表